Contrast-enhanced ultrasounds are an effective complementary tool in following up patients who undergo endovascular repair for abdominal aortic aneurysm.
Contrast-enhanced ultrasounds are an effective complementary tool in following up patients who undergo endovascular repair for abdominal aortic aneurysm, according to a study published in the journal Radiology.
Endovascular repair for abdominal aortic aneurysm (EVAR) is performed to place an endograft into the vessel to bypass the weakened area in the aorta. Currently, routine surveillance of the stent, to watch for endoleaks that raise the risk of an aneurysm sac rupture, is done by CT angiography. However there is concern regarding the use of CTs because of related ionizing radiation and potential kidney damage from the contrast agent.
Researchers from the Hospital Clinic in Barcelona, Spain, evaluated 35 patients who underwent CT angiography and an ultrasound with a second-generation contrast agent. The smaller microbubbles in the new agent do not pass through the cells that line the inner surface of the blood vessel walls. The exams were performed at one- and six-month follow up and every year thereafter, for a total of 126 performed studies.
According to Rosa Gilabert, MD, PhD, from the Hospital Clinic, in determining the presence of an endoleak, the contrast-enhanced ultrasound had a sensitivity of 97 percent, a specificity of 100 percent, and an accuracy of 99 percent. It enabled correct classification of 26 to 33 endoleaks and did not miss any that were clinically important.
“These results support that contrast-enhanced ultrasound can be integrated into EVAR follow-up,” Dr. Gilabert said.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Week, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.